Vitamin D Satus in Adults With Newly Diagnosed ITP
Launched by ASSIUT UNIVERSITY ·
Trial Information
Current as of November 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the levels of vitamin D in adults who have recently been diagnosed with a condition called ITP, which affects the blood. The researchers want to see if there is a connection between vitamin D levels and how well patients respond to treatment. Understanding this could help improve care for people with ITP in the future.
Adults of all genders between the ages of 18 and 74 who have just been diagnosed with ITP may be eligible to join the study. Participants will have their vitamin D levels checked, and their treatment progress will be monitored to see if there’s a link between vitamin D and how well they do. Right now, the study is not yet recruiting, but once it starts, participants can expect simple blood tests and regular follow-ups as part of the process.
Gender
ALL
Eligibility criteria
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported